Evidence map›Paper›PMID 39099792›Full record

ReviewInternational journal of nanomedicine2024

Recent Advancements and Trends of Topical Drug Delivery Systems in Psoriasis: A Review and Bibliometric Analysis.

Pingyu An, Qiyue Zhao, Siyu Hao, Xiaodong Wang, Jiangtian Tian, Zhiqiang Ma

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pingyu AnBasic Medical College, Harbin Medical University, Harbin, People's Republic of China.ORCID 0009-0005-2564-6750
Qiyue ZhaoSchool of Nursing, Southern Medical University, Guangzhou, People's Republic of China.ORCID 0009-0008-0342-2045
Siyu HaoDepartment of Dermatology, the Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Xiaodong WangDepartment of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.ORCID 0000-0002-7887-3421
Jiangtian TianDepartment of Cardiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.ORCID 0000-0001-8716-9164
Zhiqiang MaDepartment of Dermatology, the Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.ORCID 0009-0007-0890-4222

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psoriasis is an immune-mediated inflammatory skin disease where topical therapy is crucial. While various dosage forms have enhanced the efficacy of current treatments, their limited permeability and lack of targeted delivery to the dermis and epidermis remain challenges. We reviewed the evolution of topical therapies for psoriasis and conducted a bibliometric analysis from 1993 to 2023 using a predictive linear regression model. This included a comprehensive statistical and visual evaluation of each model's validity, literature profiles, citation patterns, and collaborations, assessing R variance and mean squared error (MSE). Furthermore, we detailed the structural features and penetration pathways of emerging drug delivery systems for topical treatment, such as lipid-based, polymer-based, metallic nanocarriers, and nanocrystals, highlighting their advantages. This systematic overview indicates that future research should focus on developing novel drug delivery systems characterized by enhanced stability, biocompatibility, and drug-carrying capacity.

Indexed as

BibliometricsDrug Delivery SystemsPsoriasisAdministration, CutaneousAdministration, TopicalDermatologic AgentsDrug CarriersHumansNanoparticlesDermatologic AgentsDrug Carriersbibliometricdrug deliverynanocarriersnanoparticlepsoriasistopical treatment

Identifiers

PMID39099792
PMCPMC11296365

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.